Chemosensitivity and endocrine sensitivity predicted by mammaprint and blueprint in the Neoadjuvant Breast Registry Symphony Trial (NBRST).
Pat W. Whitworth
No relevant relationships to disclose
Mark Gittleman
No relevant relationships to disclose
Stephanie Akbari
No relevant relationships to disclose
Lisette Stork
Employment or Leadership Position - Agendia
Femke De Snoo
Employment or Leadership Position - Agendia
Jessica Gibson
Employment or Leadership Position - Agendia
Peter D. Beitsch
No relevant relationships to disclose